Stockscreener 앱 받기
149.38
1.49%
-2.2958
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse - The Chronicle-Journal
Gilead earnings up next: Can Yeztugo launch offset Q4 softness? By Investing.com - Investing.com Australia
Gilead Sciences: Buy This Stock For Both Dividend And Growth (NASDAQ:GILD) - Seeking Alpha
Wealthfront Advisers LLC Reduces Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Stock: Yield-Rich, AI-Ignored, And Suddenly Back On Wall Street’s Radar - AD HOC NEWS
Coca-Cola, Gilead, Robinhood and more set to report earnings Tuesday - Investing.com
Gilead Sciences (GILD) Poised for Q4 Earnings Beat Amid Strong D - GuruFocus
Gilead Q4 preview: Core portfolio, Yeztugo launch keep analysts optimistic ahead of earnings - Seeking Alpha
Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? - TradingView
Should you buy Gilead Sciences before Feb. 10? - MSN
Should You Buy Gilead Sciences Before Feb. 10? - The Motley Fool
Exploring Gilead Sciences's Earnings Expectations - Benzinga
Candriam S.C.A. Has $179.86 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by ProShare Advisors LLC - MarketBeat
Alps Advisors Inc. Increases Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Reports Q4: Everything You Need To Know Ahead Of Earnings - Yahoo! Finance Canada
Early Trading Movement | Gilead Sciences-B Shares Surge Over 7%, With the 5-day MA Crossing Above the 10-day MA to Form a Golden Cross - 富途牛牛
Gilead stock at 52-week high after FDA Yescarta label change, with earnings next - TechStock²
Plato Investment Management Ltd Acquires 6,668 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Is Up 7.4% After FDA Expands Yescarta Lymphoma Label Restrictions Removed - simplywall.st
Canada Post Corp Registered Pension Plan Has $11.64 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Assessing Gilead Sciences (GILD) Valuation After Its Strong Recent Share Price Performance - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 115,640 Shares - MarketBeat
Gilead Sciences CEO O’Day sells $17.3 million in stock - Investing.com
Gilead Sciences CEO O’Day sells $17.3 million in stock By Investing.com - Investing.com India
Biopharma bites: Dosing pause for uniQure's gene therapy, EU OK for GSK's Nucala, and a label update for Gilead's CAR-T - FirstWord Pharma
Gilead’s Dietmar Berger Reflects On Pipeline After First Year As CMO - Citeline News & Insights
Gilead is advertising around the Super Bowl to get out the word about new HIV-prevention drug - The Business Journals
Is Gilead Sciences (GILD) a 'Buy' Ahead of Its Upcoming Earnings Announcement? - Yahoo Finance
Gilead (GILD) Gains FDA Nod for Expanded Use of Yescarta in Lymp - GuruFocus
FDA Updates Yescarta Label, Boosts Gilead's (GILD) Market Positi - GuruFocus
Gilead wins favorable FDA label update for Yescarta (GILD) - Seeking Alpha
Gilead Sciences Says Yescarta Won FDA Label Update, Removing Use Limits for Relapsed CNS Lymphoma Patients - marketscreener.com
Gilead Sciences (GILD) Valuation Check After Oncology And HIV Therapy Momentum - simplywall.st
J.W. Cole Advisors Inc. Purchases 7,397 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Envestnet Asset Management Inc. Lowers Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Is Gilead Sciences (GILD) Still Attractive After Strong Multi‑Year Share Price Gains - Yahoo Finance
Ahead of Gilead (GILD) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Gilead Sciences, Inc. (GILD): A bull case theory - MSN
Ashton Thomas Private Wealth LLC Acquires 10,107 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Stock Holdings Increased by Jones Financial Companies Lllp - MarketBeat
Machina Capital S.A.S. Makes New $1.65 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
ABN AMRO Bank N.V. Acquires Shares of 46,091 Gilead Sciences, Inc. $GILD - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Sells 60,982 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by AGF Management Ltd. - MarketBeat
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts - Yahoo Finance Singapore
Gilead Sciences Stock Surged 50%, Here's Why - Trefis
This Overlooked Biotech Giant Could Surprise Investors This Quarter - Barchart.com
Here's Why Gilead Sciences Stock Surged 21% in a Month - Finviz
Earnings Preview: Gilead Sciences (GILD) Q4 Earnings Expected to Decline - Yahoo Finance
Gilead Sciences (GILD) to Release Quarterly Earnings on Tuesday - MarketBeat
Principal Financial Group Inc. Trims Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica - GlobeNewswire Inc.
Gilead Sciences Oncology Push Gains Traction With Trodelvy Keytruda Results - Yahoo Finance
Gilead’s Growing Oncology Role Reshapes The Investment Case For GILD - simplywall.st
Gilead Sciences, Inc. (GILD): A Bull Case Theory - Finviz
Implied Volatility Surging for Gilead Sciences Stock Options - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) Sets New 12-Month High on Analyst Upgrade - MarketBeat
Synopsys, Rocket Companies, On Holding And A Health Care Stock On CNBC's 'Final Trades' - Benzinga
Gilead Sciences, Inc. $GILD Position Cut by TD Waterhouse Canada Inc. - MarketBeat
Atlantic Union Bankshares Corp Has $19.61 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating - Insider Monkey
Mediolanum International Funds Ltd Buys 9,971 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Thrivent Financial for Lutherans Boosts Stake in Gilead Sciences, Inc. $GILD - MarketBeat
AE Wealth Management LLC Buys 8,554 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
2.09%
1.87%
자본화:
|
볼륨(24시간):